SCHEMBL4880908

SCHEMBL4880908

CCOC(=O)c1c[nH]cc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.53
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
NOTUM Q6P988 1/20 0.52
ALDH1A1 P00352 5/20 0.47
MAPT P10636 4/20 0.47
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 4/20 0.46
POLB P06746 2/20 0.46
GAA P10253 2/20 0.46
HSD17B10 Q99714 1/20 0.46
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
ALOX15 P16050 1/20 0.44
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4045529 0.92 TSHR (0.61) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL7439372 0.82 KMT2A (0.61) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL969677 0.82 TSHR (0.55) TSHRKMT2AMEN1NOTUMALDH1A1
SCHEMBL31540155 0.80 KMT2A (0.58) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL4046233 0.80 TSHR (0.53) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL4952910 0.79 TSHR (0.57) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL11576424 0.79 TSHR (0.57) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL7263275 0.79 TSHR (0.57) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL337915 0.79 TSHR (0.57) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL828639 0.79 TSHR (0.57) TSHRKMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214533-A1 Cyclic Iminocarbamates And Their Use BAYER HEALTHCARE AG (DE) 2008-09-04 US disclosed
US-5075452-A PROCESS FOR THE PREPARATION OF 5-MEMBERED NITROGEN CONTAINING HETEROAROMATICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1991-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214533-A1 Cyclic Iminocarbamates And Their Use F2, UQCRB, F12 TSHR 1635/4885KMT2A 3720/4885MEN1 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.